MEDIVEK: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIVEK
Largest movements
- Cash +€29,687
up €29,687 (+4,396%), from €675 to €30,362
mainly Net result for the year (+€21,249) and Tax, wage and social debts (+€12,434)
- Receivables within one year +€5,155
up €5,155 (+1,310%), from €393 to €5,548
of which Trade receivables: +€5,488
- Deferred charges and accrued income +€706
new in 2025: €706
- Reserves +€19,215
new in 2025: €19,215
- Tax, wage and social debts +€12,434
new in 2025: €12,434
- Profit (loss) carried forward +€2,034
up €2,034, from -€2,034 to €0
- Accrued charges and deferred income +€1,250
new in 2025: €1,250
- Other debts +€409
up €409 (+67.9%), from €603 to €1,012
- Gross operating margin +€29,363
up €29,363, from -€1,776 to €27,587
- Taxes +€5,946
new in 2025: €5,946
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,069 | €36,616 | +€35,547 | +3,326% |
| Current assets | 29/58 | €1,069 | €36,616 | +€35,547 | +3,326% |
| Amounts receivable within one year | 40/41 | €393 | €5,548 | +€5,155 | +1,310% |
| Trade receivables | 40 | €61 | €5,548 | +€5,488 | +9,071% |
| Other amounts receivable | 41 | €333 | €0 | -€333 | -100% |
| Cash at bank and in hand | 54/58 | €675 | €30,362 | +€29,687 | +4,396% |
| Deferred charges and accrued income | 490/1 | - | €706 | +€706 | |
| Total equity and liabilities | 10/49 | €1,069 | €36,616 | +€35,547 | +3,326% |
| Equity | 10/15 | €466 | €21,715 | +€21,249 | +4,562% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | - | €19,215 | +€19,215 | |
| Distributable reserves | 133 | - | €19,215 | +€19,215 | |
| Profit (loss) carried forward | 14 | -€2,034 | €0 | +€2,034 | |
| Amounts payable | 17/49 | €603 | €14,901 | +€14,298 | +2,371% |
| Amounts payable within one year | 42/48 | €603 | €13,651 | +€13,048 | +2,164% |
| Trade debts | 44 | - | €205 | +€205 | |
| Suppliers | 440/4 | - | €205 | +€205 | |
| Taxes, remuneration and social security | 45 | - | €12,434 | +€12,434 | |
| Taxes | 450/3 | - | €12,434 | +€12,434 | |
| Other amounts payable | 47/48 | €603 | €1,012 | +€409 | +67.9% |
| Accrued charges and deferred income | 492/3 | - | €1,250 | +€1,250 | |
| Other operating charges | 640/8 | €118 | €254 | +€136 | +115% |
| Gross operating margin | 9900 | -€1,776 | €27,587 | +€29,363 | |
| Operating profit (loss) | 9901 | -€1,894 | €27,333 | +€29,227 | |
| Financial income | 75/76B | - | €3 | +€3 | |
| Recurring financial income | 75 | - | €3 | +€3 | |
| Financial charges | 65/66B | €140 | €141 | +€1 | +0.4% |
| Recurring financial charges | 65 | €140 | €141 | +€1 | +0.4% |
| Profit (loss) for the period before taxes | 9903 | -€2,034 | €27,195 | +€29,229 | |
| Income taxes | 67/77 | - | €5,946 | +€5,946 | |
| Profit (loss) for the period | 9904 | -€2,034 | €21,249 | +€23,284 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,034 | €21,249 | +€23,284 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.